Immune Restoration Therapy
Age-related immune decline & associated inflammatory diseases
Pre-clinicalActive
Key Facts
Indication
Age-related immune decline & associated inflammatory diseases
Phase
Pre-clinical
Status
Active
Company
About Rejenevie Therapeutics
Rejenevie Therapeutics is an early-stage biotech leveraging insights from parabiosis research to develop immune restoration therapies for age-related diseases. Its core approach involves using cell culture-based treatments to 'reset' the aging immune system, aiming to reduce inflammation and increase protective cells. The company has initiated patient treatments at a clinical facility in the Bahamas, positioning it as a developer with an active, early-stage clinical program. Its mission is to extend and improve patients' quality of life by targeting the fundamental biology of immune aging.
View full company profile